UA35623C2 - Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю - Google Patents

Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю

Info

Publication number
UA35623C2
UA35623C2 UA96010375A UA96010375A UA35623C2 UA 35623 C2 UA35623 C2 UA 35623C2 UA 96010375 A UA96010375 A UA 96010375A UA 96010375 A UA96010375 A UA 96010375A UA 35623 C2 UA35623 C2 UA 35623C2
Authority
UA
Ukraine
Prior art keywords
isomers
phenylcyclohexylcarboxylic
amide
derivatives
antirestenosis
Prior art date
Application number
UA96010375A
Other languages
English (en)
Russian (ru)
Inventor
Маттіас МЮЛЛЄР-ГЛІМАНН
Маттиас Мюллер-Глиманн
Ульріх Мюллєр
Ульрих Мюллер
Мартін Бойк
Мартин Бойк
Зігфрід Цайсс
Зигфрид Цайсс
Кристоф Гердес
Анке Домдай-Бетте
Руді Грютцманн
Руди Грютцманн
Штефан ЛОМЕР
Штефан ВОЛЬФАЙЛЬ
Йоцкан Ялкіноглу
Йоцкан Ялкиноглу
Дірк Денцер
Дирк ДЕНЦЕР
Джеймс Ельтінг
Джеймс Эльтинг
Original Assignee
Байєр Аг
Байер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байєр Аг, Байер Аг filed Critical Байєр Аг
Publication of UA35623C2 publication Critical patent/UA35623C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Винахід стосується нових хімічних речовин з цінними біологічними властивостями, зокрема до похідних аміду фенілциклогексилкарбонової кислоти загальної формули (1).
UA96010375A 1995-02-01 1996-01-30 Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю UA35623C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503160A DE19503160A1 (de) 1995-02-01 1995-02-01 Verwendung von Phenylcyclohexylcarbonsäureamiden

Publications (1)

Publication Number Publication Date
UA35623C2 true UA35623C2 (uk) 2001-04-16

Family

ID=7752849

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96010375A UA35623C2 (uk) 1995-02-01 1996-01-30 Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю

Country Status (31)

Country Link
US (1) US5935983A (uk)
EP (1) EP0725064A1 (uk)
JP (1) JPH08253453A (uk)
KR (1) KR960031442A (uk)
CN (1) CN1137380A (uk)
AR (1) AR002272A1 (uk)
AU (1) AU710235B2 (uk)
BG (2) BG103820A (uk)
CA (1) CA2168317A1 (uk)
CZ (1) CZ29196A3 (uk)
DE (1) DE19503160A1 (uk)
DZ (1) DZ1986A1 (uk)
EE (1) EE9600023A (uk)
FI (1) FI960425A (uk)
HR (1) HRP960017A2 (uk)
HU (1) HUP9600227A3 (uk)
IL (1) IL116931A (uk)
MA (1) MA23794A1 (uk)
NO (1) NO309841B1 (uk)
NZ (1) NZ280905A (uk)
PL (1) PL312546A1 (uk)
RO (1) RO117256B1 (uk)
RU (1) RU2158261C2 (uk)
SG (1) SG42329A1 (uk)
SK (1) SK13796A3 (uk)
SV (1) SV1996000008A (uk)
TN (1) TNSN96016A1 (uk)
TW (1) TW448176B (uk)
UA (1) UA35623C2 (uk)
YU (1) YU5896A (uk)
ZA (1) ZA96725B (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
HUP0303460A3 (en) * 2001-03-12 2004-07-28 Avanir Pharmaceuticals San Die Benzimidazole compounds for modulating ige and inhibiting cellular proliferation and pharmaceutical compositions containing them
DE10150310A1 (de) * 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
US6934951B2 (en) 2002-01-17 2005-08-23 Intel Corporation Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
EP1651198A2 (en) * 2003-08-08 2006-05-03 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226109A1 (de) * 1992-08-07 1994-02-10 Bayer Ag Verwendung von ASS zur Hemmung von Plaquebildung
DE4304455A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe

Also Published As

Publication number Publication date
YU5896A (sh) 1998-12-23
NO309841B1 (no) 2001-04-09
JPH08253453A (ja) 1996-10-01
NO960414L (no) 1996-08-02
CN1137380A (zh) 1996-12-11
SK13796A3 (en) 1996-10-02
KR960031442A (ko) 1996-09-17
CA2168317A1 (en) 1996-08-02
AU710235B2 (en) 1999-09-16
HUP9600227A2 (en) 1996-12-30
FI960425A (fi) 1996-08-02
EP0725064A1 (de) 1996-08-07
IL116931A (en) 2000-06-01
HUP9600227A3 (en) 2000-03-28
DZ1986A1 (fr) 2002-10-15
HU9600227D0 (en) 1996-03-28
DE19503160A1 (de) 1996-08-08
RU2158261C2 (ru) 2000-10-27
SV1996000008A (es) 1996-11-04
ZA96725B (en) 1996-08-20
EE9600023A (et) 1996-08-15
CZ29196A3 (en) 1996-08-14
US5935983A (en) 1999-08-10
TNSN96016A1 (fr) 2005-03-15
MA23794A1 (fr) 1996-10-01
NO960414D0 (no) 1996-01-31
BG63044B1 (bg) 2001-02-28
SG42329A1 (en) 1997-08-15
AU4224096A (en) 1996-08-08
AR002272A1 (es) 1998-03-11
FI960425A0 (fi) 1996-01-30
BG100326A (bg) 1996-08-30
BG103820A (bg) 2001-09-28
IL116931A0 (en) 1996-05-14
TW448176B (en) 2001-08-01
PL312546A1 (en) 1996-08-05
HRP960017A2 (en) 1997-12-31
NZ280905A (en) 1996-12-20
RO117256B1 (ro) 2001-12-28

Similar Documents

Publication Publication Date Title
TR199800019T1 (xx) Trombosit topaklanmas�n� �nleyici yeni maddeler.
HUP0400694A3 (en) Small molecule inhibitors of rotamase enzyme activity and pharmaceutical compositions containing the compounds
ZA964547B (en) Monkey monocional antibodies specific to human b7.1 and/or b7.2, primatized forms thereof pharmaceutical compositions containing them and use thereof as immunosuppressants
AU5707294A (en) 3,3 diphenyl prop-2-yl amino acid derivatives and their use as tachykinin antagonists
IL93090A0 (en) Platinum compounds and pharmaceutical compositions containing the same
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
UA35623C2 (uk) Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
MY115211A (en) Novel amino acid derivatives, their preparation and use
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
OA09190A (fr) "Procédés de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïques et de médicaments les contenant".
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
HUP0003174A2 (hu) 20(S)-Kamptotecin glikokonjugátumai, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
DE3683249D1 (de) 2-aminosulfonyl-6-nitrobenzoesaeureester oder amide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BR9803914A (pt) Lantibióticos relacionados a actagardina e processos para sua preparação e uso.
HK1017880A1 (en) Colchicine and thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
EE03803B1 (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
HUP9901975A3 (en) Novel n,n'-bridged bis-indolyl-maleimides, their use as intermediates and pharmaceutical compositions containing them
DE3674971D1 (en) P-acylaminobenzamide.
HUP9900863A3 (en) 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof
BR9810387A (pt) (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica